These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31429798)

  • 1. Training program-induced skeletal muscle adaptations in two men with myotonic dystrophy type 1.
    Roussel MP; Morin M; Girardin M; Fortin AM; Leone M; Mathieu J; Gagnon C; Duchesne E
    BMC Res Notes; 2019 Aug; 12(1):526. PubMed ID: 31429798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.
    Roussel MP; Morin M; Gagnon C; Duchesne E
    BMC Musculoskelet Disord; 2019 Mar; 20(1):101. PubMed ID: 30836978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength-training effectively alleviates skeletal muscle impairments in myotonic dystrophy type 1.
    Roussel MP; Hébert LJ; Duchesne E
    Neuromuscul Disord; 2020 Apr; 30(4):283-293. PubMed ID: 32340814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic training in patients with myotonic dystrophy type 1.
    Orngreen MC; Olsen DB; Vissing J
    Ann Neurol; 2005 May; 57(5):754-7. PubMed ID: 15852373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high resistance training in patients with myotonic dystrophy.
    Tollbäck A; Eriksson S; Wredenberg A; Jenner G; Vargas R; Borg K; Ansved T
    Scand J Rehabil Med; 1999 Mar; 31(1):9-16. PubMed ID: 10229998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle.
    Ikezoe K; Nakamori M; Furuya H; Arahata H; Kanemoto S; Kimura T; Imaizumi K; Takahashi MP; Sakoda S; Fujii N; Kira J
    Acta Neuropathol; 2007 Nov; 114(5):527-35. PubMed ID: 17661063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.
    Bouchard JP; Cossette L; Bassez G; Puymirat J
    J Neurol; 2015 Feb; 262(2):285-93. PubMed ID: 25380585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major involvement of trunk muscles in myotonic dystrophy type 1.
    Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
    Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelines.
    Petitclerc É; Hébert LJ; Desrosiers J; Gagnon C
    Muscle Nerve; 2015 Apr; 51(4):473-8. PubMed ID: 25399769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 9-year follow-up study of quantitative muscle strength changes in myotonic dystrophy type 1.
    Gagnon C; Petitclerc É; Kierkegaard M; Mathieu J; Duchesne É; Hébert LJ
    J Neurol; 2018 Jul; 265(7):1698-1705. PubMed ID: 29785524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiological features of patients with myotonic dystrophy type 1].
    Li M; Wang ZJ; Cui F; Yang F; Chen ZH; Ling L; Huang XS
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(5):345-7. PubMed ID: 23660205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does quantitative EMG differ myotonic dystrophy type 2 and type 1?
    Szmidt-Salkowska E; Gawel M; Lusakowska A; Nojszewska M; Lipowska M; Sulek A; Krysa W; Rajkiewicz M; Seroka A; Kaminska AM
    J Electromyogr Kinesiol; 2014 Oct; 24(5):755-61. PubMed ID: 25052913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones.
    Campos GE; Luecke TJ; Wendeln HK; Toma K; Hagerman FC; Murray TF; Ragg KE; Ratamess NA; Kraemer WJ; Staron RS
    Eur J Appl Physiol; 2002 Nov; 88(1-2):50-60. PubMed ID: 12436270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in muscle morphology, electromyographic activity, and force production characteristics during progressive strength training in young and older men.
    Häkkinen K; Newton RU; Gordon SE; McCormick M; Volek JS; Nindl BC; Gotshalk LA; Campbell WW; Evans WJ; Häkkinen A; Humphries BJ; Kraemer WJ
    J Gerontol A Biol Sci Med Sci; 1998 Nov; 53(6):B415-23. PubMed ID: 9823737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankle Strength Impairments in Myotonic Dystrophy Type 1: A Five-Year Follow-up.
    Hébert LJ; Vial C; Hogrel JY; Puymirat J
    J Neuromuscul Dis; 2018; 5(3):321-330. PubMed ID: 29889079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery.
    Mondragon-Gonzalez R; Perlingeiro RCR
    Dis Model Mech; 2018 Jul; 11(7):. PubMed ID: 29898953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.